Leptospiral immunoglobulin-like proteins elicit protective immunity

Area of Science:

• Microbiology
• Immunology
• Vaccinology

Background:

• Leptospirosis remains a significant global health concern, necessitating the development of effective vaccines.
• Current vaccines have limitations, driving the search for novel vaccine candidates.
• Leptospira interrogans is the primary causative agent of leptospirosis.

Purpose of the Study:

• To identify and characterize novel immunogenic proteins from Leptospira interrogans serovar manilae.
• To evaluate the potential of these proteins as vaccine candidates against leptospirosis.

Main Methods:

• Identification and characterization of LigA-m and LigB-m proteins from Leptospira interrogans.
• Southern blot analysis to assess gene conservation.
• Assessment of protein expression and localization (surface exposure, lipoprotein nature).
• Immunization of mice and subsequent challenge with Leptospira interrogans.
• Serological analysis using patient sera.

Main Results:

• Two homologous immunogenic proteins, LigA-m and LigB-m, were identified.
• The lig genes are conserved among pathogenic Leptospira species.
• LigA-m is a surface-exposed lipoprotein expressed during in vitro culture.
• Both LigA-m and LigB-m conferred protective immunity against homologous Leptospira interrogans serovar challenge in mice.
• Antibodies against LigA-m and LigB-m were detected in sera from patients infected with heterologous serovars.

Conclusions:

• LigA-m and LigB-m proteins are viable vaccine candidates for leptospirosis.
• These proteins demonstrate potential for a broad-spectrum leptospirosis vaccine.
• Further research is warranted to advance these candidates towards clinical application.